Legend Biotech (LEGN) EBITDA Margin (QoQ) (2019 - 2026)
Legend Biotech (LEGN) EBITDA Margin (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Legend Biotech | 8.69 Bn | 7.79 Bn | 129.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -989.00 |
| Dec 31, 2025 | 952.00 |
| Sep 30, 2025 | -13,008.00 |
| Jun 30, 2025 | 14,064.00 |
| Mar 31, 2025 | 1,601.00 |
| Dec 31, 2024 | 140.00 |
| Sep 30, 2024 | -19,894.00 |
| Jun 30, 2024 | -3,413.00 |
| Mar 31, 2024 | 8,919.00 |
| Dec 31, 2023 | -8,386.00 |
| Sep 30, 2023 | -4,010.00 |
| Jun 30, 2023 | -7,280.00 |
| Mar 31, 2023 | -10,897.00 |
| Dec 31, 2022 | -6,819.00 |
| Sep 30, 2022 | 205,555.00 |
| Jun 30, 2022 | -151,537.00 |
| Mar 31, 2022 | 16,178.00 |
| Dec 31, 2021 | 51,212.00 |
| Sep 30, 2021 | 11,138.00 |
| Jun 30, 2021 | -85,115.00 |